 .      ,      
 


   .      
   ,    .          ?      ?  ,     ?

       ,     .

        蠖       ,          .         ,          .

    100%     ,   .

! ,   ,      .        .





 

 .      ,      



La mthode hpato-dtox Mincir durablement et sans danger gr?ce au foie by Dr. Rginald Allouche  ditions Albin Michel Paris 2022

Published by arrangement with SAS Lester Literary Agency & Associates



  ..,    , 2024

 . Π , 2026


* * *











  ,  ,  





     .         ,        .

  (18471931)









       ?      ,      ?      ,    ? Ƞ ,   ,  .

,  ,  ,          ,        .     . ,        ,        .

    ,    젖       ,  , . , ,              . ߠ         10. ,                ,           .

        .          ,        .           ,     .        ,             ..     ,      ,  ,   ,            .        .

-,     . ,   ,             . Ƞ    ,         :     - ,   ,   .   ,                  ,   ,        .        ,          .

-,  ,  ,      ,           .          ,        .

, -,         ,       - ,         .       !   ,       ,    .   ,           . ,      ,       .    [1 - H.S. Warren  ., Mice are not men, PNAS, . 112, 4,  2015, E345 [  24 2014.]; Georges Chapouthier  Fran?oise Tristani-Potteaux, Le Chercheur et la souris, CNRS ditions, 2013.],      ,           .



         ,      .   ,    ,       .

     ,           :           .      , ,      ,     ,   .  , ,        .

          :      ,          .         .








     1972    .    16.       ,      ,    ,  ,  ,     . Ƞ    : , , , ,   ..   ,  ?        .

     ,        ,     .        .     ,         . ߠ   ,  ,        ,       .

   ,              . Ƞ       .     , ,  .    ,      ,          ,    .     蠖    ,       ,   .   .

      . ,        ,         蠖        17.

         . Ƞ,   ,      ,    ,    .




:  ,  


     ,           . Ѡ           ,      .          , -        .

    ,             ,  .                    .



      ,         .


      ,  ,    .     .    ,  ,                ,      ,  .  2019     38   5   340        5  19     [2 -     ()  20 2020.].  ,    ,       .          .   ,         ,     .

         (  NASH non-alcoholic steatohepatitis),          ,   .    ,            ,   ,     .      25% [3 - Z. Younossi  ., Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention, Nature Reviews Gastroenterology & Hepatology, . 15, 1,  2018., .1120.] 20% [4 - C. Estes  ., Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 20162030, Journal of Hepatology, . 69, 4,  2018., .896904.].    ,  ?   :        [5 -         . . ..].            ,     ,     ,        .

,    , ,   ,   500     ,    2- .           ,      ,      ,    .            2- .   ,          .




  !


      蠖   蠖  ,    .          , , , , , ,   ..       ,    .

 ,        ,   .         ,         ,         .       ,     ,           ,   ,       .  ,   ,            .     ,          ,         ,  .

,     ,         ,       .     ,          . Ƞ  ,    .

     .   ,    ,    ?   ,   , [6 -  蠖 ,     ,         .]   ?

  ,     ,   ,       .         .     ,                .

     ,     :    ,     ,  ,  ()  . ,         .       .   , ,      ,    ?

      ,       . ߠ     !      .        ,               . ,      ?   ,   ,     ,          .

      ,           ,            ! ߠ    .           :    .   ,         ,     .    ,       .




  :   


     ,       ,        .       85.            6067.  ,          2025 . ߠ   ,          ,        . ߠ    ,     ,        .             .      ,       ,    ,      ,   .

    蠖         .     ?   ,       .      ,          .



,         ,      .


          .

      ,        .      .               .   ,     . Ӡ        ,    ,     , , ,   .

        ,       ,          ,      :    ,  (SGPT, )   (SGT, ),   , ,  .   ,      ,       蠖 ,      .  ,          ,           ,      .    ,          ,    .

    ,   ,          ,       .   ,             .      ,      .




   


         ,       ,         .      ,      ,    ,        .           .

         ,    ,      .     ,        .     ,     ,       ,   ,    ,          .




    



1. 

            ,     . ߠ     :

       .   ,       ,  ,        .      ,      ,  ,   ,           .

  , , , ,     ,        .

    ,   ,             .


2.  

      ,           ,           .      :

     ,   ,        (, , , ),       ,     (, , , ,  .).

 ,       , ,    ,          .



    ,           ,  ,   ,         .       ,     ,   :   ,     ,      .










 ,      



   ,    ,   .      28, ࠖ 15, ࠖ 8,     1,5  2,5.            .        .



    10%  蠖       -,   .


    ,   ,     ,  ()     .       .      ,        .    ,     ,           (     ).      ,   ,           ,    .




   ?


  1,4      ,   2016  !       ,    .   ,   .   ,     .    ,    :      [7 - R. Aviram, G. Manella, G. Asher, The liver by day and night, Journal of Hepatology, .74, 5, 1 2021., .12401242.]. ߠ     .

         :

    :                .   ,    ,      ,       .               25%  30%  ,   .         .

            . ,     ,      .        ,  ,              .

            ,     2- .        ,       .    ,          !

    A, D, B12  .

  ,    .

 ,     ,    ,   ,      .

       ,   (,    )  ,     ,  .

    ,    .

  75% ,   ,    .  25%  .

            ,   ,    ..

       .      ,        .             .    (  )      .

   ,     .




  :     

                .         .            .

          , ,    ,       6  8 .    ,   .        ,             .     蠖 .              ,       .         , ,   ,   .            ,    .     !

 ,        ,             . Ӡ     ,   ,   ,         .            ,     .    40    , ,    .    !                 ,     .





    

      ,       .         .           .       ,      .         .       ,       .  ,       ,           .

  ,      ,     .                 .             .         ( ,  , ,   ..). ,    ,        .          , -        .

 , :

    ,          ;

 ,   ,   ,    65;

    IGF1 (  ),   .

              .    堖       .





     





      !


         .         circa ()  dia ().      ,          .     ,        ,       .       ,     .       ,        .     ,     ,      .

        .  ,         ,          ,  .

    ,      ,  ,  ,    蠖 ,     .  ,     蠖   .           ,               .          .


      

        ,       :  ,  ,  ,   , ,    .     ,      .       .         .

    ,      : ,     ,    .           ,    ,     .  ,             (     ,   )       .

,     ,      ,         . -       .     ,   ,     , /  .









    


          ,      .             ࠖ ,     .             ,    .   ,  ,       ,     .         .

       .   ,          .


    FGF21

   FGF21,    21,     ,            .   ,       ,   FGF21     .    ,         [8 - E. Piccinin A. Moschetta, Hepatic-specific PPAR?-FGF21 action in NAFLD, Gut, .65, 7,  2016., .10751076.].

  FGF21      ,          .   ,   FGF21    [9 - T. M. Frayling  ., A common allele in FGF21 associated with sugar intake is associated with body shape, lower total body-fat percentage, and higher blood pressure, Cell Reports, . 23, 2,  2018., .327336.].

       ,     .   FGF21             . ,       ,      .   ,     ,     ( ,    ,    .),        ,           FGF21.


  

   ,      :

          (.  (#litres_trial_promo)).

       31 (.  (#litres_trial_promo)).

       (. (#litres_trial_promo)).

      12  ,  .

  ,        .        20,            ,                  .          50,        ,  ,   .




   


   ,      ,        .     (, )   ,    . ,      ,   ,    ,          0,7  1,05 /.

      ,    ,    ,  ,     ,   .     ,        ,     .              .


 

           ,     .                         .          ,    ,    .           .     ,     .         ,   - ,       .


 

      .     ,         .

 :      1 ,      .           .          ,       : , ,    ..      ,  ,         .




    


     ,    ,   ,    ,    Ƞ         .



,        ,    ,   .


 ,            ,       . ߠ    ,  ,  ,      ,   . ,   ,        .

   ,    , , ,    ,   .  ,      ,          [10 - H. M. Harville, R. Voorman J. J. Prusakiewicz, Comparison of paraben stability in human and rat skin, Drug Metabolism Letters, . 1,  2007., .1721.]    .   ,       ,     [11 - Hao, Y. Zhang, H. Ni, J. Gao, Y. Yang, W. Xu, et L. Tao., Evaluation of the cytotoxic effects of glyphosate herbicides in human liver, lungs and nerve, Journal of Environmental Science and Health, . B., . 54, 9, 2019., .737744; P. J. Mills, C. Caussy et R.Loomba, Glyphosate excretion is associated with steatohepatitis and advanced liverfibrosis in patients with fatty liver disease, Clinical Gastroenterology and Hepatology, . 18, 3,  2020., .741743.].     ,  ,    ,            .     ,           ,       .       , ,  ,  ,    ,        .   ,    ,        ,   ,        .        ,           .

              ,        ,          . ,            .       70%      .

         ,         .

  ,     ,         .     ,           .  ,    ,      ,     .


Ϡ        

      堖     (  NASH non-alcoholic steatohepatitis),          .      ,    23%  .      (   -)[12 - World Gastroenterology Organisation Global Guidelines, Statose hpatique non alcoolique et stato-hpatite non alcoolique (     ),  2012.],       10  ꠖ       ,             ,   .

 ,            .       ,    ,      .            ,        ()    ,    , ,   .              .



   -       ,   .


          .




  .


   .

   ,     (https://www.litres.ru/pages/biblio_book/?art=74258371)  .

      Visa, MasterCard, Maestro,    ,   ,     ,  PayPal, WebMoney, ., QIWI ,       .



notes


Notes





1


H.S. Warren  ., Mice are not men, PNAS, . 112, 4,  2015, E345 [  24 2014.]; Georges Chapouthier  Fran?oise Tristani-Potteaux, Le Chercheur et la souris, CNRS ditions, 2013.




2


    ()  20 2020.




3


Z. Younossi  ., Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention, Nature Reviews Gastroenterology & Hepatology, . 15, 1,  2018., .1120.




4


C. Estes  ., Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 20162030, Journal of Hepatology, . 69, 4,  2018., .896904.




5


        . . ..




6


 蠖 ,     ,         .




7


R. Aviram, G. Manella, G. Asher, The liver by day and night, Journal of Hepatology, .74, 5, 1 2021., .12401242.




8


E. Piccinin A. Moschetta, Hepatic-specific PPAR?-FGF21 action in NAFLD, Gut, .65, 7,  2016., .10751076.




9


T. M. Frayling  ., A common allele in FGF21 associated with sugar intake is associated with body shape, lower total body-fat percentage, and higher blood pressure, Cell Reports, . 23, 2,  2018., .327336.




10


H. M. Harville, R. Voorman J. J. Prusakiewicz, Comparison of paraben stability in human and rat skin, Drug Metabolism Letters, . 1,  2007., .1721.




11


Hao, Y. Zhang, H. Ni, J. Gao, Y. Yang, W. Xu, et L. Tao., Evaluation of the cytotoxic effects of glyphosate herbicides in human liver, lungs and nerve, Journal of Environmental Science and Health, . B., . 54, 9, 2019., .737744; P. J. Mills, C. Caussy et R.Loomba, Glyphosate excretion is associated with steatohepatitis and advanced liverfibrosis in patients with fatty liver disease, Clinical Gastroenterology and Hepatology, . 18, 3,  2020., .741743.




12


World Gastroenterology Organisation Global Guidelines, Statose hpatique non alcoolique et stato-hpatite non alcoolique (     ),  2012.


